American Vanguard (NYSE:AVD) Downgraded to Buy at StockNews.com

StockNews.com cut shares of American Vanguard (NYSE:AVDGet Rating) from a strong-buy rating to a buy rating in a report released on Friday morning.

American Vanguard Price Performance

Shares of AVD stock opened at $19.89 on Friday. The firm has a market cap of $614.00 million, a P/E ratio of 22.10 and a beta of 0.87. American Vanguard has a fifty-two week low of $13.82 and a fifty-two week high of $25.99. The business’s 50 day moving average price is $21.08 and its 200-day moving average price is $21.26. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.02 and a current ratio of 1.88.

American Vanguard (NYSE:AVDGet Rating) last released its quarterly earnings results on Tuesday, August 9th. The basic materials company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.01. American Vanguard had a return on equity of 7.20% and a net margin of 4.50%. During the same quarter last year, the firm earned $0.17 EPS. On average, equities research analysts anticipate that American Vanguard will post 1.05 earnings per share for the current year.

American Vanguard Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 7th. Investors of record on Friday, September 23rd will be given a dividend of $0.025 per share. The ex-dividend date is Thursday, September 22nd. This represents a $0.10 annualized dividend and a dividend yield of 0.50%. American Vanguard’s dividend payout ratio is presently 11.11%.

Insider Activity at American Vanguard

In other news, CEO Eric G. Wintemute purchased 2,500 shares of the company’s stock in a transaction that occurred on Friday, September 9th. The shares were bought at an average cost of $19.99 per share, for a total transaction of $49,975.00. Following the completion of the transaction, the chief executive officer now directly owns 1,082,076 shares of the company’s stock, valued at approximately $21,630,699.24. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Eric G. Wintemute bought 2,500 shares of the company’s stock in a transaction on Friday, September 9th. The shares were acquired at an average cost of $19.99 per share, with a total value of $49,975.00. Following the completion of the acquisition, the chief executive officer now owns 1,082,076 shares of the company’s stock, valued at approximately $21,630,699.24. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Eric G. Wintemute bought 2,625 shares of the company’s stock in a transaction on Wednesday, September 7th. The stock was bought at an average cost of $19.00 per share, for a total transaction of $49,875.00. Following the completion of the acquisition, the chief executive officer now directly owns 1,076,934 shares of the company’s stock, valued at approximately $20,461,746. The disclosure for this purchase can be found here. 5.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Captrust Financial Advisors raised its stake in shares of American Vanguard by 85.0% in the first quarter. Captrust Financial Advisors now owns 1,417 shares of the basic materials company’s stock worth $29,000 after purchasing an additional 651 shares during the last quarter. KBC Group NV purchased a new position in shares of American Vanguard in the second quarter worth $49,000. Van ECK Associates Corp raised its stake in shares of American Vanguard by 42.1% in the first quarter. Van ECK Associates Corp now owns 3,353 shares of the basic materials company’s stock worth $68,000 after purchasing an additional 994 shares during the last quarter. Gladius Capital Management LP purchased a new position in shares of American Vanguard in the second quarter worth $76,000. Finally, Quantbot Technologies LP purchased a new position in shares of American Vanguard in the first quarter worth $80,000. Hedge funds and other institutional investors own 81.03% of the company’s stock.

About American Vanguard

(Get Rating)

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

Further Reading

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.